Items Tagged ‘Mark Truty’
November 29, 2022
Predicting pancreatic cancer outcomes prior to surgery
By Advancing the Science contributor 
By Chloe Corey Pancreatic cancer is considered one of the least survivable forms of cancer. However, in new research published in Journal of the National Comprehensive Cancer Network, Mayo Clinic investigators demonstrated a way to predict long-term survival outcomes with high accuracy prior to surgery for patients diagnosed with borderline resectable or locally advanced pancreatic […]
Tags: Ajit Goenka, Amro Abedelrahman, Christopher Hallemeier, Cornelius Thiels, CT, David Nagorney, Jennifer Leiting, Jennifer Yonkus, Kenneth Merrell, Mark Truty, Mayo Clinic Cancer Center, Michael Haddock
January 20, 2021
PET/MRI biomarkers guide personalized treatment for patients with pancreatic cancer, study finds
By Advancing the Science contributor
By Ethan Grove Positron emission tomography (PET)/MRI has changed how Mayo Clinic specialists treat patients with pancreatic cancer. Mayo Clinic pioneered the use of PET/MRI to manage pancreatic cancer. Now a new study by Ananya Panda, M.B.B.S. (@AnanyaPanda15), and colleagues systematically evaluates the strengths of PET/MRI for pancreatic ductal adenocarcinoma. In less than five years, […]
Tags: Ajit Goenka, Ananya Panda, Bradley Kemp, chemotherapy, Eric Ehman, Garima Suman, Geoffrey Johnson, Jeff Fidler, Mark Truty, MRI, nuclear medicine, pancreatic cancer
May 1, 2019
Research News Roundup-April 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. Mayo Clinic, other experts call for urgent focus on brain disease that mimics Alzheimer’s In collaboration with the University of Kentucky, the […]
Tags: advance directive, Andrea Cheville, cancer, cardiology, clinical trials, HLHS, hypoplastic left heart syndrome, Mark Truty, pancreatic cancer, quality of life, radiation therapy, Research News Roundup
December 27, 2018
Be the life [science] of the party
Looking for a scientific conversation starter for New Year’s Eve? Advancing the Science has you covered with this top-10 recap of our hottest medical research stories from 2018. With this list in your back pocket, you’ll never run out of interesting cocktail banter. And we guarantee you’ll wow your friends with your scientific smarts. #1 […]
Tags: celiac disease, end of life care, fetal surgery, gluten free, Imad Absah, liver disease, Mark Truty, maternal and fetal medicine, multiple sclerosis, nephrology, neuroimmunology, palliative care
October 3, 2018
Mayo Clinic Awarded Nation’s First Hepatobiliary SPORE Grant
The National Cancer Institute (NCI) has awarded Mayo Clinic an $11.5 million grant to fund a Specialized Program of Research Excellence (SPORE) in hepatobiliary cancer through August 2023. Headed by principal investigators Mark A. McNiven, Ph.D., and Lewis R. Roberts, M.B., Ch.B., Ph.D., the goal of the Mayo Clinic Hepatobiliary SPORE is to make discoveries […]
Tags: cancer, Chen Wang, Edward Leof, gastrointestinal cancer, Gregory Gores, John Copland III, Lewis Roberts, liver cancer, Mark McNiven, Mark Truty, Mayo Clinic Cancer Center, Michael Torbenson
July 2, 2018
A revolution in pancreatic cancer treatment
By Advancing the Science contributor
Mark Truty, M.D., has dedicated his career to giving patients with pancreatic cancer more quality time with their loved ones. Much more time. The mission is personal for him. His own father, Kazimierz Truty, a Polish immigrant and mechanic at a meatpacking plant near Chicago, died 20 years ago from pancreatic cancer at age 58. “My […]
Tags: collaboration, Mark Truty, Mayo Clinic Cancer Center, pancreatic cancer, surgery
March 15, 2016
New Treatment-Sequencing Based on Biomarker Elevation in Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of death in men and women and is projected to increase to the second leading cause of death by 2020 if there are not significant treatment advances made. Our current understanding of pancreatic cancer suggests that it is a systemic disease in most patients, meaning, that by the time of […]
Tags: biomarkers, Center for the Science of Health Care Delivery, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, pancreatic cancer, surgery, surgical outcomes
November 10, 2015
CA 19-9 tumor marker test especially important for early-stage patients, Mayo finds Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows. […]
Tags: Carlos Puig, Center for the Science of Health Care Delivery, Christopher Shubert, David Nagorney, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, Michael Farnell, Michael Kendrick, pancreatic cancer, Rory Smoot, Ryan Groeschl